Yahoo
Copenhagen - Delayed Quote DKK

Ambu A/S (AMBU-B.CO)

81.20 +2.60 (+3.31%)
At close: October 30 at 4:59:56 PM GMT+1
Chart Range Bar
Loading chart for AMBU-B.CO
  • Previous Close 78.60
  • Open 79.45
  • Bid 81.20 x --
  • Ask 81.55 x --
  • Day's Range 79.45 - 82.45
  • 52 Week Range 56.25 - 101.30
  • Volume 798,233
  • Avg. Volume 796,839
  • Market Cap (intraday) 21.165B
  • Beta (5Y Monthly) 1.38
  • PE Ratio (TTM) 42.29
  • EPS (TTM) 1.92
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield 0.41 (0.50%)
  • Ex-Dividend Date Dec 4, 2025
  • 1y Target Est 83.84

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Further, the company manufactures video capture solutions for OEMs in medical and defense imaging applications. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

www.ambu.com

5,200

Full Time Employees

September 30

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is OMX Copenhagen 25 Index (^OMXC25) .

YTD Return

AMBU-B.CO
7.73%
OMX Copenhagen 25 Index (^OMXC25)
8.24%

1-Year Return

AMBU-B.CO
20.25%
OMX Copenhagen 25 Index (^OMXC25)
15.77%

3-Year Return

AMBU-B.CO
24.04%
OMX Copenhagen 25 Index (^OMXC25)
23.77%

5-Year Return

AMBU-B.CO
55.26%
OMX Copenhagen 25 Index (^OMXC25)
0.16%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 1.64B
Earnings 156M
Profit Margin 9.51%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
500M
1B
2B
8.0%
8.5%
9.0%
9.5%

Analyst Insights

View More

Analyst Price Targets

61.00 Low
83.84 Average
81.20 Current
111.70 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.18%

  • Return on Assets (ttm)

    5.81%

  • Return on Equity (ttm)

    8.45%

  • Revenue (ttm)

    6.24B

  • Net Income Avi to Common (ttm)

    510M

  • Diluted EPS (ttm)

    1.92

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    705M

  • Total Debt/Equity (mrq)

    9.39%

  • Levered Free Cash Flow (ttm)

    206.5M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: